The Wall Street Journal estimated that blood testing startup Theranos -- founded in 2003 -- has $53 million in cash and is burning through $10 million a month in legal fees. Can it raise more capital or will its cash bleed out with a whimper before 2017 is up?
The Wall Street Journal estimated that blood testing startup Theranos -- founded in 2003 -- has $53 million in cash and is burning through $10 million a month in legal fees. Can it raise more capital or will its cash bleed out with a whimper before 2017 is up?
Share this Article
Comment on this Article
Recommended
Please to comment